Digital PCR Market
Market Study on Digital PCR: Research Institutes to Remain Dominant End User
Digital PCR Market Segmented By Instruments, Consumables, Services Product Clinical Diagnostics, Basic Research, Applied Research, Forensic Testing
Global demand for digital PCR, also known as digital polymerase chain reaction, is set to experience significant growth at 9.3% CAGR from 2021 to 2031, up from an estimated market value of around US$ 143 Mn as of 2021. As per Persistence Market Research’s projections, instruments held a substantial share of over 70% in the global digital PCR market in 2020.
As per the detailed industry analysis, Persistence Market Research reveals that digital PCR consumption accounted for 0.6% share of the overall US$ 21 Bn molecular diagnostics market in 2020.
Digital PCR Market Value (2020)
US$ 132 Mn
Projected Market Size (2031)
US$ 347 Mn
Global Market Growth Rate (2021-2031)
Key Market Players
Find Out More about the Report Coverage
- Bio-Rad Laboratories, Inc.
- Agilent Technologies
- Thermo Fisher Scientific Inc.
- Fluidigm Corp
- Formulatrix, Inc
- JN Medsys
Demand Analysis of Digital PCR from 2016 to 2020 Vs Market Outlook for 2021 to 2031
Rising adoption of diagnostic tools, introduction of droplet digital PCR, advances in the field of quantitative gene expression, and awareness and adoption of personalized precision medicine are anticipated to drive demand digital PCR.
The global dePCR market expanded at 6.5% CAGR over the past 5 years. As per projections by Persistence Market Research, the market is expected to expand at a considerable growth rate over the next ten years at a CAGR of 9.3%.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
What are the Key Opportunities on Offer for Digital PCR Providers?
Digital PCR, or dPCR, is a new quantitative PCR method that enables ultrasensitive and reproducible detection as well as quantification of nucleic acid. Development of Polymerase Chain Reaction (PCR) has led to a revolution in the field of molecular biology and biotechnology.
Development of PCR techniques such as digital PCR, or dPCR, has led to the application of dPCR in molecular genetic analysis in cancer diagnosis, mutational analysis, quantitative gene expression analysis, and assessment of allelic imbalance. Rising incidence of infectious diseases and cancer across the globe as well as emergence of rare cancer incidences have generated an urgent need for the adoption of advanced diagnostic tools and treatments to facilitate reduced disease burden.
The global digital polymerase chain reaction market is expected to witness a large amount of opportunistic focus due to utilization of their novel applications in laboratories. Application of digital PCR in medical microbiology as well as veterinary science is a major market driver in the regions of Asia and Africa.
Clinical diagnostic applications of digital PCR are just expected to present an adaptable approach over the forecast period, boosting market growth, owing to its higher efficacy and easy application.
Portable digital PCR is also utilized in novel plant species identification, veterinary disease diagnosis, and animal species identification. Thus, myriad of applications of digital PCR in fields such as clinical, food, environment, animal health, conservation, and forensics, apart from disease diagnosis, is expected to attract a large pool of consumers in the future.
Furthermore, automation of advanced digital PCR instruments has enabled scientists to process genetic samples at lower costs and with quantitative accuracy. Reduced hands-on involvement and user-interventions during program execution of high-throughput samples is the main attraction of the automation technology that saves time and reduces foreign contaminations.
Implementation of robotics in qPCR technology enables handling and processing of high-throughput samples with even the detection of very small quantity of samples onto the solid substrates platform of nylon membrane or glass slides. Owing to these advances, demand for automated digital PCR (chip-based PCR) is likely to rise in the foreseeable future.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What’s Restraining Demand for Digital PCR?
Although the applications of digital PCRs are beneficial to the molecular biology industry, high costs associated with high-tech digital PCR instruments acts as a restraining factor when compared to the cost of RT-PCR. Moreover, when digital PCR is experiencing significant growth, demand for real-time PCR still persists in applications such as genotyping and gene expression analysis, owing to lesser cost of RT PCR.
Additionally, increasing competition in Next Generation Sequencing (NGS), which has significant uses in sequencing whole genomes, whole exomes, transcriptomes, and targeted gene regions is also a factor associated with the hindrance in demand for digital PCR. Targeted next generation sequencing is more cost-effective, and may lead to restricted growth of the digital polymerase chain reaction market.
Explore Persistence Market Research’s expertise in promulgation of the business !
Why is the U.S. a Prominent Market for Digital PCR?
The U.S. market dominates North America with a market share of over 70%, and is set to experience high growth through the forecast period.
Growth of this market is driven by the presence of an established and growing healthcare system, rising demand for personalized medicines, and presence of major players in the digital PCR industry in the country.
Why is Germany Considered a Lucrative Market for Digital PCR in Europe?
Germany dominates the European market for digital PCR with a share of around 23.9%. Germany is one of the major players in pharmaceutical research & development. Targeted therapy and personalized precision medicine are leading approaches that are being developed and manifested by implementing technologies that include genetic analysis.
Germany possesses a considerable institutional funding for research & development, due to which, the quality of research has intensified in the European region. Owing to rising incidence of diseases, molecular diagnostic has become popular in the region, and application of micro array, PCR, and other genomic and proteomic research technologies is leading the precision diagnosis space.
How are Market Players Targeting the Emerging Market of China for Digital PCR?
China holds 34.7% share in the Asia Pacific market, and this share is projected to increase over the forecast period. The China market experienced rising demand through the advent of the COVID-19 pandemic.
The aid of digital PCR technology in research & development in the country further evaluates the growth of the digital PCR industry in China. Screening for COVID-19 with high efficiency and sensitive diagnostic evaluation by the National Health Commission of the People’s Republic of China involved the adoption of digital PCR, and evaluated its benefits on screening of infections.
Which Digital PCR Product is Mainly Driving Market Growth?
By product, instruments project lucrative growth at a CAGR of 9.2% till the end of the forecast period. This growth is associated with ease of use and the user-friendly aspect of digital PCR instruments.
Which Application of Digital PCR Is Considered to Be Widely Popular?
Application in clinical diagnostics holds a revenue share of 31.2% in 2021. Digital PCR for the diagnosis of parasitic infections has also gained ground. This is associated with the aim to reduce disease burden across the world.
Impact of COVID-19
The impact of the COVID-19 pandemic was measured in several aspects of the healthcare industry. The most impacted industry was diagnostics. The impact of the COVID-19 pandemic was positive on the growth of RT-PCR as well as digital PCR, which were utilized in diagnostics and drug discovery.
Major players in the industry are focused on the development of new droplet digital PCR kits for the detection of COVID-19. Several regulatory authorities have initiated the approval of such tests to manage the impact magnitude of the COVID-19 pandemic.
Many key developments of companies during the COVID-19 pandemic have been recorded.
- In January 2021, QIAGEN made an announcement of a dPCR platform “Qiacity” for wastewater and mutation testing, to increase its product portfolio of COVID-19 testing solutions.
The strategy of expansion, new product launches, and approvals by key manufacturers is strengthening their market presence. Many companies have an established presence in clinical diagnostics, such as Bio-Rad Laboratories.
- In May 2017, Thermo Fisher Scientific introduced the new capillary electrophoresis (CE) system to offer a cartridge-based system for Sanger sequencing and fragment analysis.
- In August 2017, Fluidigm Corporation entered into a licensing agreement with Baylor Genetics to deliver NGS library prep assays that empower CFTR gene used for research with the Juno System.
Similarly, recent developments related to companies manufacturing digital PCR products have been tracked by the team at Persistence Market Research, which are available in the full report.
Digital PCR Industry Report Scope
Historical Data Available for
US$ Mn for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Available upon Request
Key Segments Covered in Digital PCR Industry Research
- Clinical Diagnostics
- Basic Research
- Applied Research
- Forensic Testing
By End User
- Pharmaceutical Companies
- Research Institutes
- Forensic Labs
- Agriculture Companies
- FAQs -
The global digital PCR market is worth more than US$ 132 Mn at present.
Demand for digital PCR is estimated to surge at a CAGR of 9.3% with an estimated value of US$ 347 Mn by 2031.
Historically, from 2016 to 2020, demand for digital PCR increased at a CAGR of 6.5%.
User-friendly instruments of digital PCR, novel applications of digital PCR, and automation in advanced digital PCR instruments are some of the key trends in the market.
Increasing global funding in research & development and rising awareness about advanced molecular diagnostics are set to drive the market over the forecast period.
The U.S., Canada, Japan, Germany, and China are the top 5 countries driving demand for digital PCR.
North America holds around 34.4% revenue share (2020) in the overall global market. The U.S. remains the fastest-growing market, exhibiting a CAGR of 8.9% over the forecast period.
The Europe market is set to exhibit a CAGR of 8.5% over the forecast period, owing to the presence of key players in the region.
The U.S., Germany, and Japan are key producers of the digital PCR devices.
Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Fluidigm Corp, Formulatrix, Inc, JN Medsys and STILLA are key exporters of digital PCR products.
The China digital polymerase chain reaction market appears to uphold a share of 34.7% in APEJ, while Japan holds a revenue share of 7.7% in the global market.